Agilent Technologies, which recently completed its acquisition of BIOVECTRA, is undergoing a major organizational overhaul to drive growth and better serve its customers. The new structure, effective immediately, divides the company into three business groups focused on specific end markets:   Life Sciences and Diagnostics Markets Group (LDG): Targeting pharma, biopharma, clinical, and diagnostics markets. Applied Markets Group (AMG): Focusing on food, environmental, forensics, ch...